Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiyue Zhao

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinical Nuclear Medicine|February 20, 2024
18 F-FAPI for Imaging Metastatic Perivascular Epithelioid Cell NeoplasmJing Zhang, Miao Ke, Ruiyue Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2024
[<sup>64</sup>Cu]Cu-FAP-NOX, a N-oxalyl modified cyclic peptide for FAP PET imaging with a flexible imaging time windowShaoyu Liu, Jiawei Zhong, Ziqi Zhang, et al.
Journal of Medicinal Chemistry|July 29, 2024
<sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate CancerYang Luo, Wenbin Jin, Ran Wang, et al.
EJNMMI Radiopharmacy and Chemistry|November 17, 2025
Optimization of the radiosynthesis of the PSMA-targeting drugs [<sup>177</sup>Lu]Lu-P17-087 and [<sup>177</sup>Lu]Lu-P17-088 on the MiniLu™ automated moduleDavid Alexoff, Karl Ploessl, Ruiyue Zhao, et al.
EJNMMI Radiopharmacy and Chemistry|February 23, 2024
Optimization and scale up of production of the PSMA imaging agent [<sup>18</sup>F]AlF-P16-093 on a custom automated radiosynthesis platformDavid Alexoff, Seok Rye Choi, Karl Ploessl, et al.
Journal of Medicinal Chemistry|July 8, 2026
Development and Advantages of <i>O</i>-(Carboxymethyl)-<i>L</i>-tyrosine-Based PSMA-Targeting Theranostics for Prostate CancerLinlin Li, Ruiyue Zhao, Guochang Wang, et al.
Molecular Pharmaceutics|October 27, 2020
Synthesis and Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled (<i>R</i>)- vs (<i>S</i>)-DOTAGA Prostate-Specific Membrane Antigen-Targeting DerivativesRuiyue Zhao, Karl Ploessl, Zhihao Zha, et al.
Bioconjugate Chemistry|April 19, 2021
Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [<sup>18</sup>F]AlF-P16-093Zhihao Zha, Seok Rye Choi, Karl Ploessl, et al.
ACS Nano|October 15, 2024
Lymphocyte-Derived Engineered Apoptotic Bodies with Inflammation Regulation and Cartilage Affinity for Osteoarthritis TherapyJia Chen, Zihao Wang, Shuaibing Liu, et al.
Bioorganic Chemistry|March 19, 2026
A potent icaritin derivative ameliorates Parkinson's disease via GPER-mediated mitophagy restoration and dopaminergic neuroprotectionXiaowen Wang, Xizhen Cao, Meiyun Cai, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|February 20, 2024
18 F-FAPI for Imaging Metastatic Perivascular Epithelioid Cell NeoplasmJing Zhang, Miao Ke, Ruiyue Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2024
[<sup>64</sup>Cu]Cu-FAP-NOX, a N-oxalyl modified cyclic peptide for FAP PET imaging with a flexible imaging time windowShaoyu Liu, Jiawei Zhong, Ziqi Zhang, et al.
Journal of Medicinal Chemistry|July 29, 2024
<sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate CancerYang Luo, Wenbin Jin, Ran Wang, et al.
EJNMMI Radiopharmacy and Chemistry|November 17, 2025
Optimization of the radiosynthesis of the PSMA-targeting drugs [<sup>177</sup>Lu]Lu-P17-087 and [<sup>177</sup>Lu]Lu-P17-088 on the MiniLu™ automated moduleDavid Alexoff, Karl Ploessl, Ruiyue Zhao, et al.
EJNMMI Radiopharmacy and Chemistry|February 23, 2024
Optimization and scale up of production of the PSMA imaging agent [<sup>18</sup>F]AlF-P16-093 on a custom automated radiosynthesis platformDavid Alexoff, Seok Rye Choi, Karl Ploessl, et al.
Journal of Medicinal Chemistry|July 8, 2026
Development and Advantages of <i>O</i>-(Carboxymethyl)-<i>L</i>-tyrosine-Based PSMA-Targeting Theranostics for Prostate CancerLinlin Li, Ruiyue Zhao, Guochang Wang, et al.
Molecular Pharmaceutics|October 27, 2020
Synthesis and Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled (<i>R</i>)- vs (<i>S</i>)-DOTAGA Prostate-Specific Membrane Antigen-Targeting DerivativesRuiyue Zhao, Karl Ploessl, Zhihao Zha, et al.
Bioconjugate Chemistry|April 19, 2021
Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [<sup>18</sup>F]AlF-P16-093Zhihao Zha, Seok Rye Choi, Karl Ploessl, et al.
ACS Nano|October 15, 2024
Lymphocyte-Derived Engineered Apoptotic Bodies with Inflammation Regulation and Cartilage Affinity for Osteoarthritis TherapyJia Chen, Zihao Wang, Shuaibing Liu, et al.
Bioorganic Chemistry|March 19, 2026
A potent icaritin derivative ameliorates Parkinson's disease via GPER-mediated mitophagy restoration and dopaminergic neuroprotectionXiaowen Wang, Xizhen Cao, Meiyun Cai, et al.
Pageof 5